1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Keloids Global Clinical Trials Review, H1, 2014

Keloids Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 76 pages

Keloids Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Keloids Global Clinical Trials Review, H1, 2014" provides data on the Keloids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Keloids. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Keloids. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Keloids Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Keloids 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Keloids to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Keloids to Dermatology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Keloids 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Keloids Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Keloids 31
Dec 04, 2013: RXi Pharmaceuticals Announces mRNA Data of an Additional Cohort in the Second Phase 1 Multi-Dose Study with RXI-109, Extending the Dose Response Following Treatment in the Initial 2-week Period 31
Jun 06, 2013: RXi Pharmaceuticals Announces Positive Results In First Double Blind Study In Healthy Volunteers With RXI-109 31
Jan 30, 2013: RXi Pharma Completes Enrollment In Second Phase I Trial For RXI-109 Program 32
Mar 03, 2010: Capstone To Continue AZX100 Phase II Clinical Trial In Keloid Scarring 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Renovo Group Plc 34
Clinical Trial Overview of Renovo Group Plc 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Nippon Medical Research, Inc. 37
Clinical Trial Overview of Nippon Medical Research, Inc. 37
MS Clinical Research Pvt Ltd 38
Clinical Trial Overview of MS Clinical Research Pvt Ltd 38
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
Galena Biopharma, Inc. 40
Clinical Trial Overview of Galena Biopharma, Inc. 40
CATALYSIS, S.L. 41
Clinical Trial Overview of CATALYSIS, S.L. 41
Clinical Trial Overview of Top Institutes / Government 42
St. Luke's-Roosevelt Hospital Center 42
Clinical Trial Overview of St. Luke's-Roosevelt Hospital Center 42
Center for Genetic Engineering and Biotechnology 43
Clinical Trial Overview of Center for Genetic Engineering and Biotechnology 43
Keloid Research Foundation 44
Clinical Trial Overview of Keloid Research Foundation 44
University of Connecticut Health Center 45
Clinical Trial Overview of University of Connecticut Health Center 45
Carmel Medical Center 46
Clinical Trial Overview of Carmel Medical Center 46
University of Schleswig-Holstein 47
Clinical Trial Overview of University of Schleswig-Holstein 47
Northwestern University 48
Clinical Trial Overview of Northwestern University 48
VU University Medical Center 49
Clinical Trial Overview of VU University Medical Center 49
Herlev Hospital 50
Clinical Trial Overview of Herlev Hospital 50
Five Key Clinical Profiles 51
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76

List of Tables
Keloids Therapeutics, Global, Clinical Trials by Region, 2014* 7
Keloids Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Keloids Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Keloids Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Keloids Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Keloids Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Keloids Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Keloids Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Keloids to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Keloids Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Keloids Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Keloids to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Keloids Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Keloids Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Keloids Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Keloids Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Keloids Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Keloids Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Keloids Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Keloids Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Keloids Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Keloids Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Keloids Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Keloids Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Renovo Group Plc, 2014* 34
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 35
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 36
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Medical Research, Inc., 2014* 37
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by MS Clinical Research Pvt Ltd, 2014* 38
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 39
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Galena Biopharma, Inc., 2014* 40
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by CATALYSIS, S.L., 2014* 41
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Luke's-Roosevelt Hospital Center, 2014* 42
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Genetic Engineering and Biotechnology, 2014* 43
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Keloid Research Foundation, 2014* 44
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Connecticut Health Center, 2014* 45
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Carmel Medical Center, 2014* 46
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2014* 47
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 48
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 49
Keloids Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2014* 50

List of Figures
Keloids Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Keloids Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Keloids Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Keloids Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Keloids Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Keloids Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Keloids to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Keloids Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Keloids Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Keloids to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Keloids Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Keloids Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Keloids Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Keloids Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Keloids Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Keloids Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Keloids Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Keloids Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Keloids Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Keloids Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.